Cargando…
Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
Background: Survival from melanoma is strongly related to patient sex, with females having a survival rate almost twice that of males. Many explanations have been proposed but have not withstood critical scrutiny. Prior analysis of different cancers with a sex bias has identified six X-linked genes...
Autores principales: | Emran, Abdullah Al, Nsengimana, Jérémie, Punnia-Moorthy, Gaya, Schmitz, Ulf, Gallagher, Stuart J., Newton-Bishop, Julia, Tiffen, Jessamy C., Hersey, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464825/ https://www.ncbi.nlm.nih.gov/pubmed/32731355 http://dx.doi.org/10.3390/cancers12082082 |
Ejemplares similares
-
Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
por: Punnia-Moorthy, Gaya, et al.
Publicado: (2021) -
Sex bias of females in survival from cancer and infections. Is X the answer?
por: Emran, Abdullah Al, et al.
Publicado: (2021) -
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
por: Gallagher, Stuart J, et al.
Publicado: (2015) -
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma
por: Tiffen, Jessamy, et al.
Publicado: (2016) -
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
por: Emran, Abdullah Al, et al.
Publicado: (2020)